Cyclo Therapeutics, Inc. Warrant
CYTHW
CYTHW was delisted on the 25th of March, 2025.
2 hedge funds and large institutions have $459K invested in Cyclo Therapeutics, Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
36% more capital invested
Capital invested by funds: $337K → $459K (+$122K)
0% more funds holding
Funds holding: 2 → 2 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.91K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WVP
1
Worth Venture Partners
Fort Lee,
New Jersey
| $458K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $1K | -$2.91K | -788 | -79% |
|
CYTHW Hedge Fund Activity: Q2 2021 in Review
2 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q2 2021, worth a combined $459K — up 36% from $337K a quarter earlier.
Fund positioning in CYTHW was balanced in Q2 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $2.91K.
- 2 institutional investors held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $459K of Cyclo Therapeutics, Inc. Warrant stock for Q2 2021, up 36% quarter-over-quarter.
- 0 funds opened new Cyclo Therapeutics, Inc. Warrant positions in Q2 2021 and 0 closed out.
- The largest Cyclo Therapeutics, Inc. Warrant seller in Q2 2021 was UBS Group, an estimated $2.91K sold.
Based on aggregated 13F filings for Q2 2021.